Exit Wealth Advisors, LLC.

Position in GILD — Gilead Sciences, Inc.

CIK 2082744 ATLANTA, GA

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$221,853

-$21,208 QoQ

Shares Held

1,756

+0.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#1,863

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Exit Wealth Advisors, LLC. holds $7,658,405 across 6 Drug Manufacturers - General names. GILD ranks #6 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,922	$3,504,734
2	BMY	Bristol Myers Squibb Co	53,008	$3,054,320
3	JNJ	Johnson & Johnson	1,318	$334,732
4	MRK	Merck & Co., Inc.	2,199	$282,571
5	ABBV	AbbVie Inc.	1,034	$260,195
6	GILD	Gilead Sciences, Inc. This page	1,756	$221,853

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$221,853	1,756	+0.7%	Shares	Sole	2026-08-11
2026-03-31	$243,061	1,744	+1.1%	Shares	Sole	2026-05-11
2025-12-31	$211,726	1,725	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.